Neonatal Intensive Care Units (NICUs): Clinical and Patient Perspectives, Levels of Care and Emerging Challenges

$110.00

Series: Neonatology Research Developments
BISAC: MED070000

From World Health Organization data, the prevalence of hearing impairment among infants varies between 0.5 and 3.0 cases per thousand, but in children hospitalized in the Newborn Intensive Care Unit (NICU) and in those with other risk factors (i.e., anatomically small for gestational age, craniofacial abnormalities, intrauterine infections, family history of hearing loss, ototoxic drugs, mechanical ventilation , etc.), the prevalence is 10-20 times greater.

Newborn Intensive Care Unit (NICU) can be defined as an intensive care unit for sick newborns who need specialized treatment. NICU combines equipment and advanced technology with medical staff specially trained in newborn care. The Joint Committee on Infants Hearing (JCIH) identified many risk factors in NICU infants like prolonged mechanical ventilation, asphyxia, low birth weight and ototoxic medication, and so it also considers intensive care as a whole a risk factor.

The present book focuses its attention on this hearing loss risk factor, starting from risk factors and screening strategies, highlighting the various neonatal levels of care, focusing on the treatment of infants with neural tube defects and the future motor development of premature babies. This should be done until caregivers can get the attention of drug therapies used in the NICU. (Imprint: Nova Biomedical)

Add to Wishlist
ISBN: N/A Categories: , , , Tags: , ,

Table of Contents

Table of Contents

Preface

Chapter 1. Audiological Risk Factors and Screening Strategies in NICU Infants
Serena Rizzo, MD, Daniela Bentivegna, MD, Francesco Dispenza, MD, Marianna Mucia, MD, Fulvio Plescia, Pietro Salvago, MD, Federico Sireci, MD and Francesco Martines (University of Palermo, Bio.Ne.C. Department, Palermo, Italy, and others)

Chapter 2. Hearing Loss in Neonatal Intensive Care Units (NICUs): Follow-Up Surveillance
Federico Sireci, MD, Sergio Ferrara, MD, Rosalia Gargano, PhD, Marianna Mucia, MD, Fulvio Plescia, Serena Rizzo, MD, Pietro Salvago, MD and Francesco Martines (University of Palermo, Bio.Ne.C. Department, Palermo, Italy, and others)

Chapter 3. Standards for Levels of Neonatal Care
Francesca Maienza, MD, Thomas Ewan, PhD, Marianna Mucia, MD, Serena Rizzo, MD, Federico Sireci, MD and Rosalia Gargano, PhD (University of Palermo, Bio.Ne.C. Department, Palermo, Italy, and others)

Chapter 4. Management of Infants with Neural Tube Defects (NTDs) in NICU (pp.41-68)
Maria Ilenia Passalacqua, MD, Sergio Ferrara, Rosalia Gargano, PhD, Francesca Maienza, MD, Thomas Ewan, PhD, Marianna Mucia MD, Serena Rizzo MD and Federico Sireci, MD (University of Palermo, Bio.Ne.C. Department, Palermo, Italy, and others)

Chapter 5. The Motor Development of Preterm Infants after the Neonatal Intensive Care Unit
Thomas Ewan, PhD, Ferrara Sergio, MD, Messina Giuseppe, MD, Passalacqua Maria Ilenia, MD, Rizzo Serena, MD, Salvago Pietro MD, Palma Antonino and Martines Francesco (Sport and Exercise Sciences Research Unit, University of Palermo, Palermo, Italy, and others)

Chapter 6. Pharmacological Therapy of Newborn Babies Admitted to the Neonatal Intensive Care Unit
Fulvio Plescia, PhD, Gianluca Lavanco, Anna Brancato, Carla Cannizzaro, Francesco Dispenza, PhD, Marianna Mucia, MD, Maria Ilenia Passalacqua, MD, Pietro Salvago, MD, Federico Sireci, MD, Serena Rizzo, MD and Angela Cavallaro (University of Palermo, Department of Sciences for Health Promotion and Mother and Child Care “Giuseppe D’Alessandro,” Palermo, Italy, and others)

Editor’s Contact Information

Index

Audience: Residents and consultants

Publish with Nova Science Publishers

We publish over 800 titles annually by leading researchers from around the world. Submit a Book Proposal Now!